{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.20 vs. cons $1.16",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total production",
      "prediction": "IN-LINE",
      "answer": "pred ~7.43 Bcfe/d vs. cons 7.45 Bcfe/d",
      "confidence": "HIGH"
    },
    {
      "kpi": "Total capital expenditures",
      "prediction": "IN-LINE",
      "answer": "pred ~$805M vs. cons $808M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Total production",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.50 Bcfe/d vs. cons 7.50 Bcfe/d (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Total capital expenditures",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.85B vs. cons $2.85B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Share repurchases",
      "prediction": "LOWER",
      "answer": "guide ~$100M vs. cons $300M (2H2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "The ~$0.04 EPS beat should support day 1, but unchanged ~7.50 Bcfe/d production and ~$2.85B capex guidance imply little out-period estimate upside, while predicted 2H2026 repurchases of ~$100M versus ~$300M consensus constrain follow-through after Twin Eagle.",
  "day5_confidence": "MEDIUM"
}